bioRxiv Science⌕ Search

Biology subjects

Biefer, H. R. C.

Publications and source records attributed to Biefer, H. R. C..

2 recordsLinked to original sources

Volumetric 3D Printing and Melt-Electrowriting to Fabricate Implantable Reinforced Cardiac Tissue Patches

Cardiac patches for repairing myocardial defects require mechanically stable materials that prevent bleeding and can be implanted via suturing. The current clinical standard, bovine pericardial patches (BPPs), serve this purpose but do not degrade or integrate with the myocardium, limiting their long-term effectiveness. Therefore, we have developed the Reinforced engineered Cardiac tissue Patch (RCPatch). This multimaterial patch consists of a stiffness-tuned, cardiomyocyte-infiltrated 3D metamaterial and a suturable, hydrogel-infiltrated mesh to reduce permeability and bleeding. We first designed and computationally optimized anisotropic metamaterials using a generative modelling approach and fabricated them from biodegradable poly({varepsilon}-caprolactone) (PCL) via volumetric 3D printing (VP). The metamaterial supported the infiltration of cardiomyocytes, which maintained cell viability and contractility in vitro. In a second step, we enhanced implantability and reduced blood permeability through the patch by combining a melt-electrowritten (MEW) mesh with a fibrin hydrogel. Finally, in an acute large animal trial, the RCPatch was used on an induced myocardial defect, where it withstood intraventricular blood pressure and enabled partial hemodynamic recovery. Our findings establish a scalable framework for fabricating cardiac tissue patches that integrate mechanical reinforcement with biological function, offering a surgically implantable, and potentially regenerative solution for intraventricular myocardial repair. Table of Contents (ToC) O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=179 SRC="FIGDIR/small/642643v1_ufig1.gif" ALT="Figure 1"> View larger version (64K): org.highwire.dtl.DTLVardef@66293dorg.highwire.dtl.DTLVardef@11d9122org.highwire.dtl.DTLVardef@235d16org.highwire.dtl.DTLVardef@1b46911_HPS_FORMAT_FIGEXP M_FIG C_FIG This study presents an implantable intraventricular cardiac patch (RCPatch) combining volumetric 3D-printed metamaterials with melt-electrowritten (MEW) meshes. The design integrates tunable stiff structures with soft, cell-laden hydrogels. The RCPatch withstood suturing, intraventricular pressure, and cardiac contraction in an acute large animal myocardial defect model. The patch prevented bleeding and enabled partial hemodynamic recovery, demonstrating its potential for myocardial repair.

bioengineering↗

Restored TDCA and Valine Levels Imitate the Effects of Bariatric Surgery

Obesity is widespread and linked to various co-morbidities. Bariatric surgery has been identified as the only effective treatment, promoting sustained weight loss and the remission of co-morbidities. We performed sleeve-gastrectomies (SGx) in a pre-clinical mouse model of diet-induced obesity (DIO), delineating the effects on long-term remission from obesity. SGx resulted in sustained weight loss and improved glucose tolerance. Mass-spectrometric metabolomic profiling revealed significantly reduced systemic levels of taurodeoxycholic acid (TDCA) and L-valine in DIO mice. Notably, TDCA and L-Valine levels were restored after SGx in both human and mice to levels comparable with lean controls. Strikingly, combined systemic treatment with TDCA and valine induced a profound weight loss in DIO mice analogous to effects observed after SGx. Utilizing indirect calorimetry, we confirmed reduced food intake as causal for TDCA/valine-mediated weight loss via a central inhibition of the melanin-concentrating hormone. In summary, we identified restored TDCA/valine levels as an underlying mechanism of SGx-derived effects on weight loss. Of translational relevance, TDCA and L-valine are presented as novel agents promoting weight loss while reversing obesity-associated metabolic disorders.

cell biology↗